Results 1 to 10 of about 40,598 (248)
Medical Mycology, 2000 Major changes are occurring in the epidemiology of opportunistic infections (OI) in patients with acquired immune deficiency syndrome (AIDS) and treated with highly active antiretroviral therapy (HAART). A marked decrease of minor and major OI was observed and clinical resistance of thrush to antifungal agents became extremely rare.
Marcelo D. Martins +8 more
openaire +4 more sources
Mycoses in the transplanted patient [PDF]
Medical Mycology, 2000 The incidence of invasive fungal infection (IFI) has increased considerably over the past 20 years, and transplant recipients are at especially high risk for fungal infections owing to their overall immunosuppressed condition. Organ transplantation procedures were incorporated as a therapeutic option for many patients who lacked the normal functions of
M. T. Verón +4 more
openaire +3 more sources
Single‐Dose, Intravenous, and Oral Pharmacokinetics of Isavuconazole in Dogs
Journal of Veterinary Pharmacology and Therapeutics, EarlyView.ABSTRACT Isavuconazole, a triazole antifungal used in humans for invasive fungal infections, may be effective for treating canine fungal infections, although data on its use in dogs is limited. This study aimed to determine the pharmacokinetics and safety of a single dose of isavuconazole in dogs, administered both intravenously and orally. Six healthy
Yishan Kuo +3 more
wiley +1 more source
Veterinary Dermatology, EarlyView.Background – Sporotrichosis is a chronic, mycotic infection caused by fungi of the genus Sporothrix. Zoonotic sporotrichosis occurs mainly through S. brasiliensis transmission, resulting from the organism's traumatic introduction via scratches or bites, or contact with exudate from contaminated cats.
Steffanie Amadei +6 more
wiley +1 more source
Veterinary Dermatology, Volume 36, Issue 3, Page 302-313, June 2025.Background – Malassezia pachydermatis (MP) is implicated in severe dermatitis and otitis externa (OE) of companion animals and recently gained attention for its increasing resistance to azole compounds. For this reason, developing novel therapeutic strategies is of great interest. In a previous work, we used reference yeast isolates to evaluate several
Costanza Spadini +11 more
wiley +1 more source
Health Science Reports, Volume 8, Issue 5, May 2025.ABSTRACT Background and Aims During the COVID‐19 pandemic, the emergence of mucormycosis, a rare but often fatal fungal infection, gained significant attention due to its increased prevalence among immunocompromised patients. This study aimed to determine the prevalence and characterize the clinical features of COVID‐19‐associated mucormycosis in ...
Javad Zarei +4 more
wiley +1 more source
Journal of Clinical Laboratory Analysis, Volume 39, Issue 9, May 2025.Consumption of antifungals showed a declining trend, with the highest consumption of oral voriconazole (mean DOT/1000 pt. days 18653.49) and oral fluconazole (mean DOT/1000 pt. days 15258.14). Candida albicans was the most isolated pathogen 768 (53.60%) and among all Candida species, major resistance was found in Candida tropicalis 58 (4.05%).
Zunaira Akbar +6 more
wiley +1 more source
Pediatric Blood &Cancer, Volume 72, Issue 5, May 2025.ABSTRACT Background and Aims Invasive fungal diseases (IFD) in children with newly diagnosed acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) are poorly characterized, especially in lower–middle‐income countries (LMICs). This study aims to identify the incidence, risk factors, and outcomes of IFD in a pediatric cohort with ALL/LBL ...
Amrutha Narayana Murthy +12 more
wiley +1 more source
Journal of Veterinary Internal Medicine, Volume 39, Issue 3, May/June 2025.ABSTRACT Background Discospondylitis refers to inflammation of the intervertebral disc and adjacent vertebral endplates. The literature on mycotic discospondylitis (MD) in dogs is limited. Objective To describe clinical and advanced diagnostic imaging findings, therapeutic strategies, and outcomes in dogs with a confirmed diagnosis of MD.
Samuel Okonji +7 more
wiley +1 more source
Clinical Case Reports, Volume 13, Issue 4, April 2025.ABSTRACT Naltrexone, increasingly used for substance use disorders, can induce acute eosinophilic pneumonia. Prompt recognition through exclusion of other causes and early corticosteroid initiation can ensure rapid improvement and prevent severe complications.
Amir Davoodi +4 more
wiley +1 more source